Abstract |
The potential role of dietary fats in cancer is attracting considerable interest within the community. Both epidemiologic and experimental findings suggest that omega-3 polyunsaturated fatty acids (omega-3 PUFAs), which are almost absent from typical Western diets, exert protective effects against cancer progression, although the precise mechanism of this suppression remains unknown. One of the potential targets for omega-3 PUFAs in cancer suppression is angiogenesis, a process of new blood vessel formation within rapidly growing tumors. Here, we demonstrate that omega-6 PUFAs stimulate and omega-3 PUFAs inhibit major proangiogenic processes in human endothelial cells, including the induction of angiopoietin-2 (Ang2) and matrix metalloprotease-9, endothelial invasion, and tube formation, that are usually activated by the major omega-6 PUFA arachidonic acid. The cyclooxygenase (COX)-mediated conversion of PUFAs to prostanoid derivatives participated in modulation of the expression of Ang2. Thus, the omega-6 PUFA-derived prostaglandin E2 augmented, whereas the omega-3 PUFA-derived prostaglandin E3 suppressed the induction of Ang2 by growth factors. Our findings are consistent with the suggestion that PUFAs undergo biotransformation by COX-2 to lipid mediators that modulate tumor angiogenesis, which provides new insight into the beneficial effects of omega-3 PUFAs.
|
Authors | Melissa Szymczak, Michael Murray, Nenad Petrovic |
Journal | Blood
(Blood)
Vol. 111
Issue 7
Pg. 3514-21
(Apr 01 2008)
ISSN: 0006-4971 [Print] United States |
PMID | 18216296
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Angiopoietin-2
- Fatty Acids, Omega-3
- Fatty Acids, Omega-6
- Arachidonic Acid
- prostaglandin E3
- Cyclooxygenase 2
- PTGS2 protein, human
- Matrix Metalloproteinase 9
- Alprostadil
- Dinoprostone
|
Topics |
- Alprostadil
(analogs & derivatives, metabolism)
- Angiopoietin-2
(biosynthesis)
- Arachidonic Acid
(metabolism)
- Cells, Cultured
- Cyclooxygenase 2
(metabolism)
- Dinoprostone
(metabolism)
- Endothelial Cells
(enzymology, pathology)
- Fatty Acids, Omega-3
(metabolism, pharmacology)
- Fatty Acids, Omega-6
(metabolism, pharmacology)
- Humans
- Matrix Metalloproteinase 9
(metabolism)
- Neoplasms
(drug therapy, enzymology, pathology)
- Neovascularization, Pathologic
(drug therapy, metabolism)
|